1. Home
  2. EDSA vs NA Comparison

EDSA vs NA Comparison

Compare EDSA & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$5.68

Market Cap

56.1M

Sector

Health Care

ML Signal

HOLD

NA

Nano Labs Ltd

HOLD

Current Price

$1.87

Market Cap

46.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDSA
NA
Founded
2015
2019
Country
Canada
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
56.1M
46.0M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
EDSA
NA
Price
$5.68
$1.87
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
95.4K
46.9K
Earning Date
05-08-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$1.58
52 Week High
$20.32
$8.10

Technical Indicators

Market Signals
Indicator
EDSA
NA
Relative Strength Index (RSI) 35.31 48.52
Support Level $4.87 $1.62
Resistance Level $6.58 $2.13
Average True Range (ATR) 0.53 0.14
MACD -0.10 0.02
Stochastic Oscillator 1.63 38.39

Price Performance

Historical Comparison
EDSA
NA

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

Share on Social Networks: